Stable boron compounds pave the way for easier drug development
A major step toward simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to increase the effect or reduce side effects without breaking down the medicine. The findings are published i...
Image: Phys.org
A major step toward simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to increase the effect or reduce side effects without breaking down the medicine. The findings are published in the journal Angewandte Chemie International Edition.
Originally published at Phys.org
